CTOs on the Move

Create Orthotics and Prosthetics

www.createoandp.com

 
Create O&P offers intuitive 3D printing and digital solutions to orthotists and prosthetists worldwide. We provide the tools, training, and support for O&P practices to incorporate digital workflows into their current patient care. Modernizing your practice creates stress. We create solutions.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Orsini Healthcare

Orsini Healthcare is a Elk Grove Village, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Prudental Laboratories Inc

Prudental Laboratories Inc is a Santa Ana, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Maxant Technologies

Maxant Technologies, Inc is a Niles, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Quality Transcription

Quality Transcription is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Transgenomic

Transgenomic is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events.  Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.